AFP and hepatoblastoma: The results showed that the combination of PIVKA-II and AFP further increase the efficiency for the diagnosis of childhood hepatic tumors (AUROC = 0.891) and for the differentiation of hepatoblastoma from benign hepatic tumors (AUROC = 0.895).